Expectations trend
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsNASDAQInformation TechnologyInformation Technology ServicesSnapshot 2026-10-23
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
A matching fiscal period and sufficient coverage are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Stable leadership and management execution | The company is stable in leadership and focused on growth. | Under Pressure | Additional key executive departures within next 4 quarters | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Return to profitability and positive free cash flow | A primary condition in CSP, Inc.'s published investment case. The stated target is Positive free cash flow yield and net profit by FY27. | Broken | Continued negative free cash flow and net losses beyond FY27 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Achieve full year revenue growth compared to fiscal 2025 | Management aims full year growth over 2025. | Broken | Revenue growth falls below 6% YoY in FY26 | Revenue: $14.398M FY2026-Q3; GAAP. Published target: Revenue grows beyond $16.012M in Q2 2026 and sustains growth through FY26. Target period is not explicitly aligned with this observation. Source published Aug 14, 202614,398,000 USD · source valueSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2026-Q3 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: b27f0ee1-0dc8-409f-9ec3-3419378cd03f. Source status: eligible. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Sep 25–Oct 24 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Dec 15, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a high-risk, loss-making growth business rather than a proven durable compounder. The long-term thesis is in a watch state: management priorities remain on track in parts, while recent financial performance is weak relative to its industry cohort.
The valuation evidence describes CSPI as cheap versus peers, with an expectations gap that suggests limited confidence in its prospects. The valuation score rose from 40.4 to 58.2, but the snapshot does not give a clear measure of how much growth the market assumes.
Near term, results may remain uneven: revenue was lower for the first nine months of 2026 than in the same period a year earlier, despite Technology Solutions revenue growth in the second quarter. Management says it remains on track for full-year growth and points to AZT PROTECT deployments and backlog conversion, though vendor hardware delays and weak recent performance remain risks.
The multi-year thesis depends on converting backlog into revenue and expanding AZT PROTECT deployments while delivering full-year growth. Near term, a guidance cut would be a negative signal; rate cuts or continued strong results and guidance from sector peers could support the broader technology backdrop.
Over the next 1 to 3 years, the case depends on management turning stated priorities into steadier growth, while high risk and weak recent performance keep the evidence mixed. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.